Gagnon Securities LLC Purchases 3,158 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Key Points

• Gagnon Securities LLC increased its holdings in ICU Medical, Inc. by 10.9% in Q1, acquiring 3,158 shares for a total of 32,039 shares valued at approximately $4.45 million.
• ICU Medical reported earnings per share of $1.72 for the last quarter, exceeding analysts' expectations of $1.23, and revenues increased by 6.7% year-over-year to $599.49 million.
• Analysts show a consensus rating of "Buy" for ICU Medical, with a target price of $192.67, following multiple upgrades and report revisions from various financial institutions.

Gagnon Securities LLC grew its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 10.9% in the first quarter, according to its most recent filing with the SEC. The fund owned 32,039 shares of the medical instruments supplier's stock after acquiring an additional 3,158 shares during the period. Gagnon Securities LLC owned 0.13% of ICU Medical worth $4,449,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. American Century Companies Inc. raised its position in ICU Medical by 8.4% during the 4th quarter. American Century Companies Inc. now owns 3,101 shares of the medical instruments supplier's stock worth $481,000 after purchasing an additional 241 shares during the last quarter. LPL Financial LLC raised its position in ICU Medical by 2.0% during the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock worth $747,000 after purchasing an additional 93 shares during the last quarter. Pictet Asset Management Holding SA raised its position in ICU Medical by 11.8% during the 4th quarter. Pictet Asset Management Holding SA now owns 3,287 shares of the medical instruments supplier's stock worth $510,000 after purchasing an additional 346 shares during the last quarter. O Shaughnessy Asset Management LLC bought a new position in ICU Medical during the 4th quarter worth $249,000. Finally, Alliancebernstein L.P. raised its position in ICU Medical by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock worth $4,051,000 after purchasing an additional 136 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Stock Performance

Shares of ICU Medical stock opened at $126.89 on Thursday. The company has a current ratio of 2.59, a quick ratio of 1.52 and a debt-to-equity ratio of 0.75. The business has a 50-day moving average price of $130.58 and a two-hundred day moving average price of $140.98. ICU Medical, Inc. has a 1-year low of $121.11 and a 1-year high of $196.26. The company has a market cap of $3.12 billion, a P/E ratio of -33.13 and a beta of 0.88.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, topping analysts' consensus estimates of $1.23 by $0.49. The firm had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. ICU Medical had a positive return on equity of 6.75% and a negative net margin of 3.87%. The business's revenue was up 6.7% compared to the same quarter last year. During the same period last year, the business posted $0.96 EPS. As a group, analysts anticipate that ICU Medical, Inc. will post 4.11 EPS for the current year.

Analyst Upgrades and Downgrades

ICUI has been the subject of several analyst reports. Wall Street Zen raised ICU Medical from a "hold" rating to a "buy" rating in a research report on Sunday, May 18th. KeyCorp decreased their price target on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Finally, Raymond James Financial decreased their price target on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a report on Friday, May 9th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, ICU Medical currently has a consensus rating of "Buy" and a consensus target price of $192.67.

Insider Transactions at ICU Medical

In other news, Director Elisha W. Finney sold 600 shares of the firm's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $138.92, for a total value of $83,352.00. Following the completion of the sale, the director directly owned 3,252 shares in the company, valued at $451,767.84. This trade represents a 15.58% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Ben Sousa sold 2,000 shares of the firm's stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $137.36, for a total value of $274,720.00. Following the completion of the sale, the insider owned 479 shares of the company's stock, valued at approximately $65,795.44. This represents a 80.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 36,097 shares of company stock valued at $4,860,156. 1.50% of the stock is currently owned by corporate insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.